Smoking Cessation

A 4-year Follow-up Evaluation Of A Pharmacist-managed Smoking Cessation Programme With Emphasis On Effectiveness Of Different Treatment Modalities


Introduction:
Smoking cessation clinic (SCC) was introduced into Singapore’s healthcare setting to combat the increase in smoking prevalence. This study aims to determine (1)the effectiveness of a pharmacist-managed SCC, and (2)the association between abstinence rates and different treatment modalities, in Changi General Hospital.

Methods:

445 patients who had attended the SCC were retrospectively reviewed. These patients received structured smoking cessation counselling with or without additional cessation aid comprising of nicotine replacement therapy (NRT), varenicline or bupropion. The study end points were point-prevalence abstinence rates (1)for all subjects, and (2)associated with various treatment modalities, at the final SCC review, 6- and 12-month follow-up.

Results:
The point-prevalence abstinence rates for all patients at completion of SCC review, 6- and 12-month follow-up were 19.8%, 23.8% (p=0.033), and 25.4% (p=0.009), respectively. Abstinence rates between 6- and 12-month follow-up were not statistically different. A significant association between abstinence rates and the use of pharmacotherapy was detected at 6-months’ follow-up (p=0.005), but not at SCC review completion or 12-months’ follow-up (p>0.05). Abstinence rates were highest at 6- and 12-month with use of varenicline (37.4% and 34.3%, respectively) followed by combination NRT (21.7% and 26.1%). Furthermore, patients who had received only smoking cessation counselling had abstinence rates of 20.7% and 26.0% at 6- and 12-month follow-up.

Conclusions:
Patient participation in a pharmacist-managed SCC was associated with significantly improved abstinence rates at 6- and 12-months following programme completion. The use of pharmacotherapy was significantly associated with overall abstinence rates at 6-months’ follow-up with varenicline appearing as the most effective smoking cessation aid.

Read the full article on www.tobaccopreventioncessation.com

Invitation to youth workshop: New technologies and novel tobacco products

How Big Tobacco has become the contemporary Pied Piper and possible solutions from youth advocacy: the case study of TFAC Be part of change! ENSPNext and the Sapienza University...

Read more
POLICY BRIEF: Supporting youth engagement in policy-making as a dual weapon against the Tobacco, Nicotine and Vaping Industry

The Tobacco Industry is the backbone of the biggest public health threat fueled by the most addictive and deadly product. For decades, this industry has been responsible for millions...

Read more
Letter to the Spanish Minister of Health from the Tobacco Control Community

In response to the open letter that pro-vaping organizations, with suspicious relations to the tobacco industry, sent to the new Minister of Health requesting to include vaping products in...

Read more